(MedPage Today) — ORLANDO — Most adults with type 1 diabetes switching from an insulin pump or multiple daily injections to inhaled insulin (Afrezza) needed to increase their dose of the inhaled product to achieve target glycemic control, an…
Source link : https://www.medpagetoday.com/meetingcoverage/aace/115636
Author :
Publish date : 2025-05-17 18:45:00
Copyright for syndicated content belongs to the linked Source.
